Dr. Marie-Sophie de Konig reviews the findings of the GIPS-IV trial, which was the first study to test the use of sodium thiosulfate for treating myocardial infarction in humans.
advertisement
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Recommended
Details
Overview
Dr. Marie-Sophie de Konig reviews the findings of the GIPS-IV trial, which was the first study to test the use of sodium thiosulfate for treating myocardial infarction in humans.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?